| 摘要 |
The present application provides a compound of formula (I) or a salt thereof, wherein R7, R8, R9, G, and X are as defined herein. This application further describes compositions comprising the same. Compounds of formula (I) and their salts have aPKC inhibitory activity, and may be used to treat proliferative disorders. |
| 申请人 |
CANCER RESEARCH TECHNOLOGY LIMITED;IGNYTA, INC. |
发明人 |
BRESLIN, HENRY, J.;DORSEY, BRUCE, D.;DUGAN, BENJAMIN, J.;FOWLER, KATHERINE, M.;HUDKINS, ROBERT, L.;MESAROS, EUGEN, F.;MONCK, NATHANIEL, JT;MORRIS, EMMA, L.;OLOWOYE, IKEOLUWA;OTT, GREGORY, R.;PAVE, GREGOIRE, A.;ROFFEY, JONATHAN, R. A.;SOUDY, CHRISTELLE, N.;TAO, MING;ZIFICSAK, CRAIG, A.;ZULLI, ALLISON, L. |
